EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility

Daisy J A Oketch iD, Matteo Giulietti, Francesco Piva

International Journal of Molecular Sciences · 27.12.2023 · 25 (1) · 391

DOI: 10.3390/ijms25010391 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.12.2023. Verfasst von Daisy J A Oketch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, 60131 Ancona, Italy. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, characterized by high tumor heterogeneity and a poor prognosis. Inter- and intra-tumoral heterogeneity in PDAC is a major obstacle to effective PDAC treatment; therefore, it is highly desirable to explore the tumor heterogeneity and underlying mechanisms for the improvement of PDAC prognosis. Gene copy number variations (CNVs) are increasingly recognized as a common and heritable source of inter-individual variation in genomic sequence. In this review, we outline the origin, main characteristics, and pathological aspects of CNVs. We then describe the occurrence of CNVs in PDAC, including those that have been clearly shown to have a pathogenic role, and further highlight some key examples of their involvement in tumor development and progression. The ability to efficiently identify and analyze CNVs in tumor samples is important to support translational research and foster precision oncology, as copy number variants can be utilized to guide clinical decisions. We provide insights into understanding the CNV landscapes and the role of both somatic and germline CNVs in PDAC, which could lead to significant advances in diagnosis, prognosis, and treatment. Although there has been significant progress in this field, understanding the full contribution of CNVs to the genetic basis of PDAC will require further research, with more accurate CNV assays such as single-cell techniques and larger cohorts than have been performed to date.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansDNA Copy Number VariationsPrecision MedicineGene Dosage

Stichwörter der Autor:innen

copy number variations (CNVs)non-allelic homologous recombination (NAHR)pancreatic ductal adenocarcinoma (PDAC)patient stratification

Autor:innen und Institutionen

  • Department of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.

ORCID-Profile: Daisy J A Oketch

Zitieren

APA

Oketch, D. J. A., Giulietti, M., & Piva, F. (2023). Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility. International Journal of Molecular Sciences, 25(1), 391. https://doi.org/10.3390/ijms25010391

Vancouver

Oketch DJA, Giulietti M, Piva F. Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility. International Journal of Molecular Sciences. 2023;25(1):391. doi:10.3390/ijms25010391

BibTeX
@article{Oketch2023,
  author = {Oketch, Daisy J A and Giulietti, Matteo and Piva, Francesco},
  title = {Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {25},
  number = {1},
  pages = {391},
  doi = {10.3390/ijms25010391}
}
Kostenlos starten →